LEXINGTON, Ky.--(BUSINESS WIRE)--Demeetra, a gene editing technologies company, is proud to announce that its research in collaboration with Variation Biosciences, Inc. “VBI” has been selected for an ...
The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
What if you could flip a genetic switch to silence a gene, then turn it back on with a simple drug? For researchers, gene-switch tools offer that kind of control—and a new system called Cyclone may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback